Introduction
Process validation for coated tablets is a critical area in pharmaceutical manufacturing that ensures consistency, quality, and regulatory compliance of the final dosage form. This blog focuses on validation principles specific to film-coated and sugar-coated tablets, highlighting critical quality attributes (CQAs), critical process parameters (CPPs), sampling strategies, in-process controls, and lifecycle approach per regulatory guidance. M.Pharm students will find focused multiple-choice questions that probe coating process optimization, scale-up challenges, analytical and PAT tools, statistical evaluation, and troubleshooting common coating defects. These MCQs are designed to deepen understanding and prepare students for academic exams and practical validation tasks in industry.
Q1. Which of the following is the most critical quality attribute (CQA) directly affected by the tablet coating process?
- Dissolution profile of the finished tablet
- Tablet core porosity
- API chemical structure
- Packaging material
Correct Answer: Dissolution profile of the finished tablet
Q2. According to the FDA process validation lifecycle, which stage involves defining commercial manufacturing process and identifying CPPs and CQAs?
- Continued Process Verification
- Process Qualification
- Process Design
- Change Control
Correct Answer: Process Design
Q3. In coating operations, which parameter most directly influences film thickness and weight gain per tablet?
- Pan speed alone
- Spray rate and solids content of coating suspension
- Die fill depth
- Tablet core assay
Correct Answer: Spray rate and solids content of coating suspension
Q4. Which PAT (Process Analytical Technology) tool is commonly used for real-time monitoring of coating uniformity by measuring film moisture or solvent content?
- Near Infrared Spectroscopy (NIR)
- High Performance Liquid Chromatography (HPLC)
- Gas Chromatography (GC)
- Thermogravimetric Analysis (TGA)
Correct Answer: Near Infrared Spectroscopy (NIR)
Q5. A common physical defect characterized by coarse, rough surface on film-coated tablets is known as:
- Pitting
- Orange peel
- Bridging
- Blooming
Correct Answer: Orange peel
Q6. Which of the following is a critical process parameter (CPP) that affects adhesion and plasticizer distribution in film coating?
- Inlet air temperature and humidity
- API particle size in the core
- Tablet imprint depth
- Final packaged carton dimensions
Correct Answer: Inlet air temperature and humidity
Q7. During scale-up of coating from lab to production, which dimensionless factor is most useful to maintain similar droplet behavior?
- Reynolds number and spray droplet Weber number equivalence
- Tablet diameter ratio only
- Number of coating pans
- API potency
Correct Answer: Reynolds number and spray droplet Weber number equivalence
Q8. Which in-process control is most appropriate to monitor to avoid overwetting and sticking during aqueous film coating?
- Core tablet tensile strength
- Outlet air temperature and tablet bed temperature
- Colour of the coating suspension
- Final tablet blister integrity
Correct Answer: Outlet air temperature and tablet bed temperature
Q9. For validation qualification of a coating process, the minimum number of consecutive batches typically recommended by regulatory guidance to demonstrate reproducibility is:
- One commercial batch
- Two consecutive batches
- Three consecutive batches
- Ten consecutive batches
Correct Answer: Three consecutive batches
Q10. Which statistical index indicates whether a coating process is capable of meeting specification limits with adequate margin (commonly used target)?
- R-squared
- Process capability index (Cpk) ≥1.33
- p-value < 0.05
- Standard deviation alone
Correct Answer: Process capability index (Cpk) ≥1.33
Q11. In tablet coating validation, which sampling plan best supports demonstrating batch uniformity for coating weight gain?
- Single tablet from the batch center
- Random composite of all tablets in a batch
- Stratified sampling from multiple locations (top, middle, bottom of bed)
- Only off-specification tablets
Correct Answer: Stratified sampling from multiple locations (top, middle, bottom of bed)
Q12. Which coating defect results from rapid solvent evaporation causing film cracking or chipping?
- Bridging
- Cracking
- Chalking
- Peeling due to plasticizer excess
Correct Answer: Cracking
Q13. For enteric-coated tablets, what is the primary CQA that must be validated specifically for the coating?
- Immediate disintegration in 0.1 N HCl
- Resistance to acid (no release in gastric pH) and release in intestinal pH
- Uniform colour only
- Moisture uptake during storage
Correct Answer: Resistance to acid (no release in gastric pH) and release in intestinal pH
Q14. Which device adjustment in a spray coating system most directly changes droplet size?
- Atomization air pressure
- Coating suspension pH
- Tablet core hardness
- Final blister pack sealing torque
Correct Answer: Atomization air pressure
Q15. Residual solvent limits in coatings are controlled primarily because of:
- Effect on tablet color only
- Toxicity risks, quality and stability concerns
- Increase in tablet hardness
- Enhancement of dissolution rate
Correct Answer: Toxicity risks, quality and stability concerns
Q16. Which accelerated stability test parameter is most relevant to evaluate coating adhesion and gloss retention?
- Storage under refrigerated conditions only
- High humidity and elevated temperature stress (e.g., 40°C/75% RH)
- Immersion in 0.1 N HCl for 1 hour only
- Gamma irradiation at production dose
Correct Answer: High humidity and elevated temperature stress (e.g., 40°C/75% RH)
Q17. During coating validation, an observed upward trend in coating weight variability across batches should prompt investigation of which root cause first?
- API polymorphic form change
- Variability in solids content of coating suspension or spray rate drift
- Change in tablet blister carton supplier
- Analytical HPLC column age
Correct Answer: Variability in solids content of coating suspension or spray rate drift
Q18. Which of the following is an appropriate acceptance criterion for content uniformity after coating when no assay-affecting interactions are expected?
- All tablets must be within 50–150% of label claim
- Use USP content uniformity limits (e.g., acceptance value criteria) or defined assay limits typically 85–115%
- Only average assay matters, individual tablets not required
- Assay can vary widely as long as dissolution passes
Correct Answer: Use USP content uniformity limits (e.g., acceptance value criteria) or defined assay limits typically 85–115%
Q19. Which technique is most suitable for measuring film coating thickness nondestructively during development?
- Cross-sectional microscopy only (destructive)
- Terahertz pulsed imaging or optical coherence tomography (nondestructive)
- Loss on drying of the core
- Friability test
Correct Answer: Terahertz pulsed imaging or optical coherence tomography (nondestructive)
Q20. A validated coating process requires periodic re-evaluation. Which activity best describes Continued Process Verification (CPV) for coated tablets?
- One-time qualification of equipment
- Ongoing monitoring of critical parameters and product quality attributes with trending and corrective actions
- Replacing analytical methods annually regardless of performance
- Performing full revalidation after every batch
Correct Answer: Ongoing monitoring of critical parameters and product quality attributes with trending and corrective actions

I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com
